Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.06 EUR | +1.74% | -5.13% | +43.18% |
Apr. 29 | Abivax: share price rises as two analysts express optimism | CF |
Apr. 29 | Piper Sandler Starts Abivax With Overweight Rating, $42 Price Target | MT |
Evolution of the average Target Price on Abivax
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Abivax
Guggenheim | |
Piper Sandler | |
Morgan Stanley |
EPS Revisions
- Stock Market
- Equities
- ABVX Stock
- Consensus Abivax